The Toxicology Investigators Consortium 2024 Annual Report
- PMID: 41501581
- PMCID: PMC12834888
- DOI: 10.1007/s13181-025-01099-0
The Toxicology Investigators Consortium 2024 Annual Report
Abstract
Established in 2010, the American College of Medical Toxicology (ACMT) Toxicology Investigators Consortium (ToxIC) Core Registry has systematically captured data from in-hospital and clinic-based medical toxicology physician consultations across the United States (US) and internationally. The ToxIC Core Registry contains deidentified patient data, including patient demographics, reason for medical toxicology evaluation, exposure agents, clinical signs and symptoms, treatments and antidotes administered, and mortality outcomes. This fifteenth annual report provides data from 8,868 patients entered into the Core Registry in 2024, bringing the total number of cases to 111,276 between 2010 and 2024. These cases were submitted by 41 participating sites encompassing 67 distinct hospitals over 23 US states and 3 international countries. In 2024, ethanol was the most commonly reported exposure agent class (17.8%), followed by opioids (15.8%), non-opioid analgesics (10.5%), and sympathomimetic agents (7.6%). A total of 107 fatalities were reported, corresponding to a case fatality rate of 1.2%. Additional descriptive analyses in this annual report were conducted to describe trends for opioid and psychoactive exposures between 2010 and 2024.
Keywords: Epidemiology; Medical toxicology; Overdose; Poisoning; Surveillance.
© 2025. American College of Medical Toxicology.
Conflict of interest statement
Declarations. Conflict of interest: [KA, SL, MC, AF, RC, PW, JB]: These authors have no conflicts of interest to report.
References
-
- Spyres MB, Padilla GK, Gerkin RD, Hoyte CO, Wolk BJ, Ruha AM, et al. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab’)2 (equine) antivenom and crotalidae immune polyvalent fab (ovine) antivenom reported to the North American snakebite sub-registry. Clin Toxicol Phila. 2022;60(7):838–42. - DOI - PubMed
-
- Opioid Response Network. About Us [Internet]. 2025 [cited 2025 Aug 10]. Available from: https://opioidresponsenetwork.org/about-us/
-
- Schwarz E, Buchanan J, Aldy K, Shulman J, Krotulski A, Walton S, et al. Notes from the field: detection of Medetomidine among patients evaluated in emergency departments for suspected opioid overdoses — Missouri, Colorado, and Pennsylvania, September 2020–December 2023. MMWR Morb Mortal Wkly Rep. 2024;73(30):672–4. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
